U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06821789) titled 'Effects of LRa05 and LCr86 on Bacterial Vaginosis and Ovarian Function in Women' on Feb. 06.
Brief Summary: In this study, Lacticaseibacillus rhamnosus LRa05 and Lactobacillus crispatus LCr86 were selected as test preparations to observe their clinical efficacy in the intervention trial of combined antibiotic therapy, and to evaluate their effects on the cure rate, recurrence rate and vaginal microbiota of patients with bacterial vaginitis.
Study Start Date: March 15
Study Type: INTERVENTIONAL
Condition:
Patients With Bacterial Vaginosis
Intervention:
DIETARY_SUPPLEMENT: LRa05
The experimental phase of this study will last 8 ...